Diabetic Nephropathy in Pregnancy: Suboptimal Hypertensive Control Associated With Preterm Delivery

American Journal of Hypertension

Volumn 19, Issue 5, 2006, Pages 513-519

  Carr, Darcy B ^a   Koontz, Gretchen L ^a,b   Gardella, Carolyn ^a   Holing, Emily V ^a   Brateng, Debra A ^a   Brown, Zane A ^a   Easterling, Thomas R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

Diabetic nephropathy; hypertension; pregnancy; preterm delivery

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL HYPERTENSION; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIAC OUTPUT; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; INFANT, NEWBORN; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 33646113590     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.12.010     Document Type: Article

References (30)

1. Khoury J.C., Miodovnik M., LeMasters G., and Sibai B.M. Pregnancy outcome and progression of diabetic nephropathy. What's next?. J Maternal Fetal and Neonatal Med 11 (2002) 238-244
2. Kitzmiller J.L., Brown E.R., Phillippe M., Stark A.R., Acker D., Kaldany A., Singh S., and Hare J.W. Diabetic nephropathy and perinatal outcome. Am J Obstet Gynecol 141 (1981) 741-751
3. Reece E.A., Coustan D.R., Hayslett J.P., Holford T., Coulehan J., O'Connor T.Z., and Hobbins J.C. Diabetic nephropathy. pregnancy performance and fetomaternal outcome. Am J Obstet Gynecol 159 (1988) 56-66
4. Gordon M., Landon M.B., Samuels P., Hissrich S., and Gabbe S.G. Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy. Obstet Gynecol 87 (1996) 401-409
5. Combs C.A., Rosenn B., Kitzmiller J.L., Khoury J.C., Wheeler B.C., and Miodovnik M. Early-pregnancy proteinuria in diabetes related to preeclampsia. Obstet Gynecol 82 (1993) 802-807
6. Sibai B.M., Caritis S., Hauth J., Lindheimer M., Van Dorsten J.P., MacPherson C., Klebanoff M.A., Landon M., Miodovnik M., Paul R., Meis P., Dombrowski M., Thurnau G., Roberts J., McNellis D., and National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. Am J Obstet Gynecol 182 (2000) 364-369
7. Hansson L., Zanchetti A., Carruthers S.G., Dahlof B., Elmfeldt D., Julius S., Menard J., Rahn K.H., Wedel H., and Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension. principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351 (1998) 1755-1762
8. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ 317 (1998) 703-713
9. Lewis E.J., Hunsicker L.G., Bain R.P., and Rohde R.D. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329 (1993) 1456-1462
10. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 27 Suppl 1 (2004) S15-S35
11. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., Jones D.W., Materson B.J., Oparil S., Wright J.T., and Roccella E.J. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. the JNC 7 report. JAMA 289 (2003) 2560-2572
12. Easterling T.R., Watts D., Schmucker B., and Benedetti T. Measurement of cardiac output during pregnancy. validation of Doppler technique and clinical observations in preeclampsia. Obstet Gynecol 69 (1987) 845-850
13. Easterling T.R., Carlson K., Schmucker B., Brateng D., and Benedetti T. Measurement of cardiac output in pregnancy by Doppler technique. Am J Perinat 7 (1990) 220-222
14. Easterling T.R., Benedetti T., Schmucker B., and Millard S. Maternal hemodynamics in normal and preeclamptic pregnancies. a longitudinal study. Obstet Gynecol 76 (1990) 1061-1069
15. Easterling T.R., Brateng D., Schmucker B., Brown Z., and Millard S. Prevention of preeclampsia. a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. Obstet Gynecol 93 (1999) 725-733
16. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
17. Quadri K.H., Bernardini J., Greenberg A., Laifer S., Syed A., and Holley J.L. Assessment of renal function during pregnancy using a random urine protein to creatinine ratio and Cockcroft-Gault formula. Am J Kidney Dis 24 (1994) 416-420
18. Easterling T.R., Carr D.B., Brateng D., Diederichs C., and Schmucker B. Treatment of hypertension in pregnancy. effect of atenolol on maternal disease, preterm delivery, and fetal growth. Obstet Gynecol 98 (2001) 427-433
19. Easterling T.R., Benedetti T., Schmucker B., and Carlson K. Antihypertensive therapy in pregnancy directed by noninvasive hemodynamic monitoring. Am J Perinatol 6 (1989) 86-89
20. Zar J.H. The binominal distribution. Biostatistical Analysis (1984), Prentice-Hall, Englewood Cliffs, NJ 386-397
21. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus. results of the HOPE study and MICRO-HOPE substudy. Lancet 355 (2000) 253-259
22. The EUCLID Study Group. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 349 (1997) 1787-1792
23. The Microalbuminuria Captopril Study Group. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. Diabetologia 39 (1996) 587-593
24. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G., and The Heart Outcomes Prevention Evaluation Study Investigators. Effect of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342 (2000) 145-153
25. Shaughnessy A.F., and Slawson D.C. What happened to the valid POEMs? A survey of review articles on the treatment of type 2 diabetes. BMJ 327 (2003) 266
26. Merz C.N.B., Buse J.B., Tuncer D., and Twillman G.B. Physician attitudes and practices and patient awareness of the cardiovascular complications of diabetes. J Am Coll Cardiol 40 (2002) 1877-1881
27. Berlowitz D.R., Ash A.S., Hickey E.C., Glickman M., Friedman R., and Kader B. Hypertension management in patients with diabetes. Diabetes Care 26 (2003) 355-359
28. Holing E.V., Beyer C.S., Brown Z.A., and Connell F.A. Why don't women with diabetes plan their pregnancies?. Diabetes Care 21 (1998) 889-895
29. Bar J., Chen R., Schoenfeld A., Orvieto R., Yahav J., Ben-Rafael Z., and Hod M. Pregnancy outcome in patients with insulin dependent diabetes mellitus and diabetic nephropathy treated with ACE inhibitors before pregnancy. J Ped Endocrin Metabolism 12 (1999) 659-665
30. Hod M., van Dijk D.J., Karp M., Weintraub N., Rabinerson J., Bar J., Peled Y., Erman A., Boner G., and Ovadia J. Diabetic nephropathy and pregnancy. the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome. Nephrol Dial Transplant 10 (1995) 2328-2333